Adma Biologics (ADMA) Total Debt Growth (3y) (2015 - 2025)
Adma Biologics (ADMA) Total Debt Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Adma Biologics |
1.98 Bn |
1.89 Bn |
88.82 Mn |
-20.36% |
| Date | Value |
|---|
| Dec 31, 2025 |
-20.36% |
| Sep 30, 2025 |
-19.98% |
| Jun 30, 2025 |
-19.33% |
| Mar 31, 2025 |
-19.38% |
| Dec 31, 2024 |
-8.64% |
| Sep 30, 2024 |
2.40% |
| Jun 30, 2024 |
11.77% |
| Mar 31, 2024 |
11.89% |
| Dec 31, 2023 |
11.99% |
| Sep 30, 2023 |
20.04% |
| Mar 31, 2023 |
113.07% |
| Dec 31, 2022 |
112.39% |
| Sep 30, 2022 |
27.73% |
| Jun 30, 2022 |
27.49% |
| Mar 31, 2022 |
50.16% |
| Dec 31, 2021 |
53.09% |
| Sep 30, 2021 |
85.16% |
| Jun 30, 2021 |
84.87% |
| Mar 31, 2021 |
84.60% |
| Dec 31, 2020 |
84.34% |
